Tilray Brands, Inc. (TLRY)
9.455
-0.26
(-2.63%)
USD |
NASDAQ |
Jan 16, 16:00
9.46
0.00 (0.00%)
After-Hours: 20:00
Tilray Brands EPS Diluted (Quarterly): -0.4072 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -43.51M |
| Revenue (Quarterly) | 217.51M |
| Total Expenses (Quarterly) | 262.44M |
| Enterprise Value | 1.092B |
| Gross Profit Margin (Quarterly) | 24.43% |
| Profit Margin (Quarterly) | -20.00% |
| Earnings Yield | -233.9% |
| Normalized Earnings Yield | -66.81 |